Forty years of structural imaging in psychosis: promises and truth

Acta Psychiatrica Scandinavica

Volumn 134, Issue 3, 2016, Pages 207-224

  Fusar Poli, P ^a,b   Meyer Lindenberg, A ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b South London and Maudlsey   (United Kingdom)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

computerized tomography; magnetic resonance imaging; neuroimaging; psychosis; schizophrenia

Indexed keywords

BIOLOGICAL MARKER; DOPAMINE;

AMYGDALA; BASAL GANGLION; BIPOLAR DISORDER; BRAIN ASYMMETRY; BRAIN ATROPHY; BRAIN SIZE; COGNITIVE AGING; CORTICAL THICKNESS (BRAIN); DIAGNOSTIC VALUE; EFFECT SIZE; ELECTROENCEPHALOGRAM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC RISK; GOLD STANDARD; GRAY MATTER; HIPPOCAMPUS; HUMAN; MACHINE LEARNING; MAJOR DEPRESSION; MEDIAL TEMPORAL LOBE; META ANALYSIS (TOPIC); NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; POSITRON EMISSION TOMOGRAPHY; PREMOTOR CORTEX; PRIORITY JOURNAL; PSYCHOSIS; QUALITATIVE RESEARCH; REVIEW; SCHIZOPHRENIA; SOMATOSENSORY CORTEX; SYSTEMATIC REVIEW; THALAMUS; VOXEL BASED MORPHOMETRY;

EID: 84981287672     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12619     Document Type: Review

References (136)

1. Kilgore EJ, Elster AD. Walter Dandy and the history of ventriculography. Radiology 1995;194:657–660.
2. Sampath P, Long DM, Brem H. The Hunterian Neurosurgical Laboratory: the first 100 years of neurosurgical research. Neurosurgery 2000;46:184–194; discussion 94-5.
3. Fusar-Poli P, Allen P, McGuire P. Egas Moniz (1875-1955), the father of psychosurgery. Br J Psychiatry 2008;193:50.
4. Ligon BL. Biography: history of developments in imaging techniques: Egas Moniz and angiography. Semin Pediatr Infect Dis 2003;14:173–181.
5. Raju TN. The Nobel chronicles. 1979: Allan MacLeod Cormack (b 1924); and Sir Godfrey Newbold Hounsfield (b 1919). Lancet 1999;354:1653.
6. Montgomery BJ. CT scanning recognized with Nobel Prize. JAMA 1979;242:2380.
7. Geva T. Magnetic resonance imaging: historical perspective. Cardiovasc Magn Reson 2006;8:573–580.
8. Pincock S. US and UK researchers share Nobel prize. Paul C Lauterbur and Peter Mansfield share award for seminal work on MRI. Lancet 2003;362:1203.
9. Johnstone EC, Crow TJ, Frith CD, Husband J, Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976;2:924–926.
10. Gur RE, Keshavan MS, Lawrie SM. Deconstructing psychosis with human brain imaging. Schizophr Bull 2007;33:921–931.
11. de Gruttola VG, Clax P, Demets DL et al. Considerations in the evaluation of surrogate endpoints in clinical trials. Summary of a National Institutes of Health workshop. Control Clin Trials 2001;22:485–502.
12. Kumra S, Giedd JN, Vaituzis AC et al. Childhood-onset psychotic disorders: magnetic resonance imaging of volumetric differences in brain structure. Am J Psychiatry 2000;157:1467–1474.
13. Kasai K, Shenton ME, Salisbury DF et al. Differences and similarities in insular and temporal pole MRI gray matter volume abnormalities in first-episode schizophrenia and affective psychosis. Arch Gen Psychiatry 2003;60:1069–1077.
14. Pantelis C, Velakoulis D, McGorry PD et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003;361:281–288.
15. Palaniyappan L, Marques TR, Taylor H et al. Cortical folding defects as markers of poor treatment response in first-episode psychosis. JAMA Psychiatry 2013;70:1031–1040.
16. Eack SM, Hogarty GE, Cho RY et al. Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry 2010;67:674–682.
17. Lieberman J, Jody D, Geisler S et al. Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry 1993;50:369–376.
18. Phillips ML. Neuroimaging in psychiatry: bringing neuroscience into clinical practice. Br J Psychiatry 2012;201:1–3.
19. Linden DE. The challenges and promise of neuroimaging in psychiatry. Neuron 2012;73:8–22.
20. Dazzan P. Neuroimaging biomarkers to predict treatment response in schizophrenia: the end of 30 years of solitude? Dialogues Clin Neurosci 2014;16:491–503.
21. Shenton ME, Whitford TJ, Kubicki M. Structural neuroimaging in schizophrenia: from methods to insights to treatments. Dialogues Clin Neurosci 2010;12:317–332.
22. Lassere MN. The Biomarker-Surrogacy Evaluation Schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints. Stat Methods Med Res 2008;17:303–340.
23. Mechelli A, Prata D, Kefford C, Kapur S. Predicting clinical response in people at ultra-high risk of psychosis: a systematic and quantitative review. Drug Discovery Today 2015;20:924–927.
24. Cohen BM, Buonanno F, Keck PE Jr, Finklestein SP, Benes FM. Comparison of MRI and CT scans in a group of psychiatric patients. Am J Psychiatry 1988;145:1084–1088.
25. Lieberman JA, Jody D, Alvir JM et al. Brain morphology, dopamine, and eye-tracking abnormalities in first-episode schizophrenia. Prevalence and clinical correlates. Arch Gen Psychiatry 1993;50:357–368.
26. van Erp TGM, Hibar DP, Rasmussen JM et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry 2016;21:585. doi:10.1038/mp.2015.118.
27. Ashburner J, Friston KJ. Voxel-based morphometry–the methods. NeuroImage 2000;11:805–821.
28. Maguire EA, Gadian DG, Johnsrude IS et al. Navigation-related structural change in the hippocampi of taxi drivers. Proc Natl Acad Sci USA 2000;97:4398–4403.
29. Sowell ER, Levitt J, Thompson PM et al. Brain abnormalities in early-onset schizophrenia spectrum disorder observed with statistical parametric mapping of structural magnetic resonance images. Am J Psychiatry 2000;157:1475–1484.
30. Dazzan P, Morgan K, Orr K et al. The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain 2004;127:143–153.
31. Mechelli A, Riecher-Rossler A, Meisenzahl EM et al. Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. Arch Gen Psychiatry 2011;68:489–495.
32. Tan HY, Chen AG, Chen Q et al. Epistatic interactions of AKT1 on human medial temporal lobe biology and pharmacogenetic implications. Mol Psychiatry 2012;17:1007–1016.
33. Ivleva EI, Bidesi AS, Keshavan MS et al. Gray matter volume as an intermediate phenotype for psychosis: bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry 2013;170:1285–1296.
34. Monuki ES, Walsh CA. Mechanisms of cerebral cortical patterning in mice and humans. Nat Neurosci 2001;4(Suppl):1199–1206.
35. Wiegand LC, Warfield SK, Levitt JJ et al. An in vivo MRI study of prefrontal cortical complexity in first-episode psychosis. Am J Psychiatry 2005;162:65–70.
36. Vidal CN, Rapoport JL, Hayashi KM et al. Dynamically spreading frontal and cingulate deficits mapped in adolescents with schizophrenia. Arch Gen Psychiatry 2006;63:25–34.
37. Goldman AL, Pezawas L, Mattay VS et al. Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability. Arch Gen Psychiatry 2009;66:467–477.
38. Bakken TE, Bloss CS, Roddey JC et al. Association of genetic variants on 15q12 with cortical thickness and cognition in schizophrenia. Arch Gen Psychiatry 2011;68:781–790.
39. van Lutterveld R, van den Heuvel MP, Diederen KMJ et al. Cortical thickness in individuals with non-clinical and clinical psychotic symptoms. Brain 2014;137:2664–2669.
40. Hoptman MJ, Antonius D, Mauro CJ, Parker EM, Javitt DC. Cortical thinning, functional connectivity, and mood-related impulsivity in schizophrenia: relationship to aggressive attitudes and behavior. Am J Psychiatry 2014;171:939–948.
41. Lesh TA, Tanase C, Geib BR et al. A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia. JAMA Psychiatry 2015;72:226–234.
42. Chung Y, Jacobson A, He G et al. Prodromal symptom severity predicts accelerated gray matter reduction and third ventricle expansion among clinically high risk youth developing psychotic disorders. Mol Neuropsychiatry 2015;1:13–22.
43. Shihabuddin L, Buchsbaum MS, Hazlett EA et al. Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia. Arch Gen Psychiatry 2001;58:877–884.
44. McCarley RW, Salisbury DF, Hirayasu Y et al. Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia. Arch Gen Psychiatry 2002;59:321–331.
45. Wassink TH, Epping EA, Rudd D et al. Influence of ZNF804a on brain structure volumes and symptom severity in individuals with schizophrenia. Arch Gen Psychiatry 2012;69:885–892.
46. Addington AM, Gornick MC, Shaw P et al. Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories. Mol Psychiatry 2007;12:195–205.
47. Cannon TD, van Erp TG, Huttunen M et al. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry 1998;55:1084–1091.
48. Vogeley K, Tepest R, Pfeiffer U et al. Right frontal hypergyria differentiation in affected and unaffected siblings from families multiply affected with schizophrenia: a morphometric mri study. Am J Psychiatry 2001;158:494–496.
49. van Erp TG, Saleh PA, Rosso IM et al. Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. Am J Psychiatry 2002;159:1514–1520.
50. Seidman LJ, Faraone SV, Goldstein JM et al. Left hippocampal volume as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric study of nonpsychotic first-degree relatives. Arch Gen Psychiatry 2002;59:839–849.
51. Cannon TD, van Erp TG, Rosso IM et al. Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry 2002;59:35–41.
52. van Erp TG, Saleh PA, Huttunen M et al. Hippocampal volumes in schizophrenic twins. Arch Gen Psychiatry 2004;61:346–353.
53. McDonald C, Bullmore ET, Sham PC et al. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry 2004;61:974–984.
54. McDonald C, Marshall N, Sham PC et al. Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. Am J Psychiatry 2006;163:478–487.
55. Gilmore JH, Kang C, Evans DD et al. Prenatal and neonatal brain structure and white matter maturation in children at high risk for schizophrenia. Am J Psychiatry 2010;167:1083–1091.
56. Velakoulis D, Wood SJ, Wong MT et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry 2006;63:139–149.
57. Koutsouleris N, Meisenzahl EM, Davatzikos C et al. Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry 2009;66:700–712.
58. Koutsouleris N, Meisenzahl EM, Borgwardt S et al. Individualized differential diagnosis of schizophrenia and mood disorders using neuroanatomical biomarkers. Brain 2015;138:2059–2073.
59. Crossley NA, Mechelli A, Scott J et al. The hubs of the human connectome are generally implicated in the anatomy of brain disorders. Brain 2015;137:2382–2395.
60. Mathew I, Gardin TM, Tandon N et al. Medial temporal lobe structures and hippocampal subfields in psychotic disorders: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. JAMA Psychiatry 2014;71:769–777.
61. Arango C, Rapado-Castro M, Reig S et al. Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry 2012;69:16–26.
62. Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 2011;68:128–137.
63. Prasad KM, Eack SM, Goradia D et al. Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study. Am J Psychiatry 2011;168:822–830.
64. Takahashi T, Wood SJ, Yung AR et al. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Arch Gen Psychiatry 2009;66:366–376.
65. Brans RG, van Haren NE, van Baal GC, Schnack HG, Kahn RS, Hulshoff POLHE. Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia. Arch Gen Psychiatry 2008;65:1259–1268.
66. Keller J, Shen L, Gomez RG et al. Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression. Am J Psychiatry 2008;165:872–880.
67. Koo MS, Levitt JJ, Salisbury DF, Nakamura M, Shenton ME, McCarley RW. A cross-sectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis. Arch Gen Psychiatry 2008;65:746–760.
68. Kuroki N, Shenton ME, Salisbury DF et al. Middle and inferior temporal gyrus gray matter volume abnormalities in first-episode schizophrenia: an MRI study. Am J Psychiatry 2006;163:2103–2110.
69. Coryell W, Nopoulos P, Drevets W, Wilson T, Andreasen NC. Subgenual prefrontal cortex volumes in major depressive disorder and schizophrenia: diagnostic specificity and prognostic implications. Am J Psychiatry 2005;162:1706–1712.
70. Ho BC, Alicata D, Mola C, Andreasen NC. Hippocampus volume and treatment delays in first-episode schizophrenia. Am J Psychiatry 2005;162:1527–1529.
71. Lieberman JA, Tollefson GD, Charles C et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 2005;62:361–370.
72. Nierenberg J, Salisbury DF, Levitt JJ, David EA, McCarley RW, Shenton ME. Reduced left angular gyrus volume in first-episode schizophrenia. Am J Psychiatry 2005;162:1539–1541.
73. Suzuki M, Zhou SY, Takahashi T et al. Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis. Brain 2005;128:2109–2122.
74. Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 2004;161:473–479.
75. Ettinger U, Kumari V, Chitnis XA, et al. Volumetric neural correlates of antisaccade eye movements in first-episode psychosis. Am J Psychiatry 2004;161:1918–1921.
76. Gogtay N, Sporn A, Clasen LS et al. Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses. Arch Gen Psychiatry 2004;61:17–22.
77. Prasad KM, Patel AR, Muddasani S, Sweeney J, Keshavan MS. The entorhinal cortex in first-episode psychotic disorders: a structural magnetic resonance imaging study. Am J Psychiatry 2004;161:1612–1619.
78. Ho BC, Alicata D, Ward J et al. Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am J Psychiatry 2003;160:142–148.
79. Kasai K, Shenton ME, Salisbury DF et al. Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am J Psychiatry 2003;160:156–164.
80. Kasai K, Shenton ME, Salisbury DF et al. Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 2003;60:766–775.
81. Keshavan MS, Sanders RD, Sweeney JA et al. Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. Am J Psychiatry 2003;160:1298–1304.
82. Szeszko PR, Goldberg E, Gunduz-Bruce H et al. Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia. Am J Psychiatry 2003;160:2190–2197.
83. Lee CU, Shenton ME, Salisbury DF et al. Fusiform gyrus volume reduction in first-episode schizophrenia: a magnetic resonance imaging study. Arch Gen Psychiatry 2002;59:775–781.
84. Sumich A, Chitnis XA, Fannon DG et al. Temporal lobe abnormalities in first-episode psychosis. Am J Psychiatry 2002;159:1232–1235.
85. Ettinger U, Chitnis XA, Kumari V, et al. Magnetic resonance imaging of the thalamus in first-episode psychosis. Am J Psychiatry 2001;158:116–118.
86. Hulshoff Pol HE, Schnack HG, Mandl RC et al. Focal gray matter density changes in schizophrenia. Arch Gen Psychiatry 2001;58:1118–1125.
87. Matsumoto H, Simmons A, Williams S et al. Superior temporal gyrus abnormalities in early-onset schizophrenia: similarities and differences with adult-onset schizophrenia. Am J Psychiatry 2001;158:1299–1304.
88. Fannon D, Chitnis X, Doku V et al. Features of structural brain abnormality detected in first-episode psychosis. Am J Psychiatry 2000;157:1829–1834.
89. Hirayasu Y, McCarley RW, Salisbury DF et al. Planum temporale and Heschl gyrus volume reduction in schizophrenia: a magnetic resonance imaging study of first-episode patients. Arch Gen Psychiatry 2000;57:692–699.
90. Hoff AL, Sakuma M, Razi K, Heydebrand G, Csernansky JG, Delisi LE. Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia. Am J Psychiatry 2000;157:1824–1828.
91. Hirayasu Y, Shenton ME, Salisbury DF et al. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 1999;156:1091–1093.
92. Rapoport JL, Giedd JN, Blumenthal J et al. Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 1999;56:649–654.
93. Robinson D, Woerner MG, Alvir JM et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999;56:241–247.
94. Velakoulis D, Pantelis C, McGorry PD et al. Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Arch Gen Psychiatry 1999;56:133–141.
95. Hirayasu Y, Shenton ME, Salisbury DF et al. Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. Am J Psychiatry 1998;155:1384–1391.
96. Keshavan MS, Rosenberg D, Sweeney JA, Pettegrew JW. Decreased caudate volume in neuroleptic-naive psychotic patients. Am J Psychiatry 1998;155:774–778.
97. Zipursky RB, Lambe EK, Kapur S, Mikulis DJ. Cerebral gray matter volume deficits in first episode psychosis. Arch Gen Psychiatry 1998;55:540–546.
98. Frazier JA, Giedd JN, Hamburger SD et al. Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia. Arch Gen Psychiatry 1996;53:617–624.
99. Frazier JA, Giedd JN, Kaysen D et al. Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment. Am J Psychiatry 1996;153:564–566.
100. Bilder RM, Wu H, Bogerts B et al. Absence of regional hemispheric volume asymmetries in first-episode schizophrenia. Am J Psychiatry 1994;151:1437–1447.
101. Munafo MR, Stothart G, Flint J. Bias in genetic association studies and impact factor. Mol Psychiatry 2009;14:119–120.
102. Haijma SV, Van Haren N, Cahn W, Koolschijn PC, Hulshoff Pol HE, Kahn RS. Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophr Bull 2013;39:1129–1138.
103. Fusar-Poli P, Radua J, McGuire P, Borgwardt S. Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies. Schizophr Bull 2012;38:1297–1307.
104. Frances A. RDoC is necessary, but very oversold. World Psychiatry 2014;13:47–49.
105. Kapur S, Phillips AG, Insel TR. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol Psychiatry 2012;17:1174–1179.
106. Insel T. Transforming Diagnosis. [Web] NIMH Director's Blog: NIMH; 2013 [updated 2013; cited 2015 Oct 12]; Available from: http://www.nimh.nih.gov/about/director/2013/transforming-diagnosis.shtml.
107. Excellence Nifhac. Structural neuroimaging in first-episode psychosis; 2008 Contract No.: Document Number|.
108. Fava GA. Road to nowhere. World Psychiatry 2014;13:49–50.
109. Parnas J. The RDoC program: psychiatry without psyche? World Psychiatry 2014;13:46–47.
110. Sommer IE, de Kort GA, Meijering AL et al. How frequent are radiological abnormalities in patients with psychosis? A review of 1379 MRI scans. Schizophr Bull 2013;39:815–819.
111. Fusar-Poli P, Cappucciati M, Borgwardt S et al. Heterogeneity of risk for psychosis within subjects at clinical high risk: meta-analytical stratification. JAMA Psychiatry 2016;73:113–120.
112. Fusar-Poli P, Cappucciati M, Bonoldi I et al. A momentary lapse of reason: meta-analytical prognosis of brief psychotic episodes. JAMA Psychiatry 2016;73:211–220.
113. Pina-Camacho L, Del Rey-Mejias A, Janssen J et al. Age at first episode modulates diagnosis-related structural brain abnormalities in psychosis. Schizophr Bull 2016;42:344–357.
114. Frazier JA, Hodge SM, Breeze JL et al. Diagnostic and sex effects on limbic volumes in early-onset bipolar disorder and schizophrenia. Schizophr Bull 2008;34:37–46.
115. de Peri L, Crescini A, Deste G, Fusar-Poli P, Sacchetti E, Vita A. Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies. Curr Pharm Des 2012;18:486–494.
116. Jorgensen KN, Skjaervo I, Morch-Johnsen L et al. Cigarette smoking is associated with thinner cingulate and insular cortices in patients with severe mental illness. J Psychiatry Neurosci 2015;40:241–249.
117. Morgan KD, Dazzan P, Morgan C et al. Differing patterns of brain structural abnormalities between black and white patients with their first episode of psychosis. Psychol Med 2010;40:1137–1147.
118. Rapp C, Walter A, Studerus E et al. Cannabis use and brain structural alterations of the cingulate cortex in early psychosis. Psychiatry Res 2013;214:102–108.
119. Ioannidis JP, Munafo MR, Fusar-Poli P, Nosek BA, David SP. Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention. Trends in Cognitive Sciences. 2014;18:235–241.
120. Ioannidis JP. Excess significance bias in the literature on brain volume abnormalities. Arch Gen Psychiatry 2011;68:773–780.
121. Fusar-Poli P, Radua J, Frascarelli M et al. Evidence of reporting biases in voxel-based morphometry (VBM) studies of psychiatric and neurological disorders. Hum Brain Mapp 2014;35:3052–3065.
122. Shepherd AM, Laurens KR, Matheson SL, Carr VJ, Green MJ. Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev 2012;36:1342–1356.
123. Jordan MI, Mitchell TM. Machine learning: trends, perspectives, and prospects. Science 2015;349:255–260.
124. Gifford G, Crossley N, Fusar-Poli P et al. Using neuroimaging to help predict the onset of psychosis. Neuroimage 2016. doi:10.1016/j.neuroimage.2016.03.075. [Epub ahead of print].
125. Veronese E, Castellani U, Peruzzo D, Bellani M, Brambilla P. Machine learning approaches: from theory to application in schizophrenia. Comput Math Methods Med 2013;2013:867924.
126. Brodersen KH, Deserno L, Schlagenhauf F et al. Dissecting psychiatric spectrum disorders by generative embedding. Neuroimage Clin 2014;4:98–111.
127. Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM. The clinical use of structural MRI in Alzheimer disease. Nature reviews. Neurology 2010;6:67–77.
128. McKhann GM, Knopman DS, Chertkow H et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263–269.
129. Albert MS, Dekosky ST, Dickson D et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:270–279.
130. Sperling RA, Aisen PS, Beckett LA et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:280–292.
131. Langa KM, Levine DA. The diagnosis and management of mild cognitive impairment: a clinical review. JAMA 2014;312:2551–2561.
132. Goodkind M, Eickhoff SB, Oathes DJ et al. Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry 2015;72:305–315.
133. Mills KL, Tamnes CK. Methods and considerations for longitudinal structural brain imaging analysis across development. Dev Cogn Neurosci 2014;9:172–190.
134. Munafo MR, Brown SM, Hariri AR. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry 2008;63:852–857.
135. Mier D, Kirsch P, Meyer-Lindenberg A. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol Psychiatry 2010;15:918–927.
136. Franke B, Stein JL, Ripke S et al. Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept. Nat Neurosci 2016;19:420–431.